N-(3-methoxypropyl)-1-methyl-4-piperidinamine disuccinate, 95.0%, 5g

2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

(2-Chloro-5-(trifluoromethyl)pyridin-3-yl)methanol, 95.0%, 5g

1-METHYL-2-PHENYL-5-PROPAN-2-YL-PYRAZOL-3-ONE, 90.0%, 250mg

2-(4-Amino-3-methyl-pyrazol-1-yl)-2-methyl-propanenitrile, 98%, 500mg

3,4,5-Trifluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl, 98.0%, 10g

(S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride, 97.0%, 1g

3-AMINOOXETANE-3-CARBONITRILE HCL, 95.0%, 1g

2-Ethyl-1,3,4-oxadiazole, 95.0%, 5g

GC capillary column ROTI®Cap-1, 10 m, 0.32 mm, 5.00 µm, 1 Piece(s)

N-(Pyrimidin-4-yl)acetamide, 98%, 100mg

3-Bromo-5-isoxazolecarboxaldehyde, 95.0%, 1g

2-Bromo-3-(trifluoromethyl)benzenesulfonyl chloride, 97.0%, 1g